PT885215E - Novos derivados de pirrolidina substituidos com benzo-1,3-dioxolilo e benzofuranilo como antagonistas de endotelina - Google Patents
Novos derivados de pirrolidina substituidos com benzo-1,3-dioxolilo e benzofuranilo como antagonistas de endotelinaInfo
- Publication number
- PT885215E PT885215E PT97905816T PT97905816T PT885215E PT 885215 E PT885215 E PT 885215E PT 97905816 T PT97905816 T PT 97905816T PT 97905816 T PT97905816 T PT 97905816T PT 885215 E PT885215 E PT 885215E
- Authority
- PT
- Portugal
- Prior art keywords
- benzofuranilo
- dioxolyl
- benzo
- derivatives substituted
- pyrrolidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60062596A | 1996-02-13 | 1996-02-13 | |
| US79450697A | 1997-02-04 | 1997-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT885215E true PT885215E (pt) | 2006-08-31 |
Family
ID=27083659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97905816T PT885215E (pt) | 1996-02-13 | 1997-02-12 | Novos derivados de pirrolidina substituidos com benzo-1,3-dioxolilo e benzofuranilo como antagonistas de endotelina |
Country Status (17)
| Country | Link |
|---|---|
| EP (2) | EP0885215B1 (pt) |
| JP (1) | JP2002504081A (pt) |
| KR (1) | KR100508200B1 (pt) |
| CN (2) | CN1091768C (pt) |
| AR (1) | AR006309A1 (pt) |
| AT (1) | ATE323697T1 (pt) |
| AU (1) | AU2262097A (pt) |
| BR (1) | BR9707509A (pt) |
| CA (2) | CA2634973A1 (pt) |
| CZ (1) | CZ296660B6 (pt) |
| DE (1) | DE69735710T2 (pt) |
| DK (1) | DK0885215T3 (pt) |
| ES (1) | ES2259803T3 (pt) |
| IL (2) | IL125177A0 (pt) |
| NZ (1) | NZ330818A (pt) |
| PT (1) | PT885215E (pt) |
| WO (1) | WO1997030045A1 (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208517B1 (en) | 1994-08-19 | 2007-04-24 | Abbott Labortories | Endothelin antagonists |
| DE19743681A1 (de) * | 1997-10-02 | 1999-04-08 | Knoll Ag | Methode zur Verhinderung der Transplantatabstoßung |
| US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
| WO2000004179A1 (en) * | 1998-07-15 | 2000-01-27 | Bristol-Myers Squibb Company | Stereoselective reductive amination of ketones |
| EP1114022A1 (en) * | 1998-09-14 | 2001-07-11 | Abbott Laboratories | Process for producing stereoselective nitro compounds |
| TWI306760B (en) * | 2000-08-07 | 2009-03-01 | Abbott Lab | Use of an endothelin et-a receptor antagonist and orally delivered pharmaceutical composition comprising the same |
| WO2002017912A1 (en) * | 2000-08-31 | 2002-03-07 | Abbott Laboratories | Endothelin antagonists |
| EP1601666A2 (en) | 2002-07-02 | 2005-12-07 | Schering Corporation | New neuropeptide y y5 receptor antagonists |
| FR2874015B1 (fr) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| WO2009026517A2 (en) | 2007-08-22 | 2009-02-26 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
| PL2227466T3 (pl) * | 2007-11-30 | 2011-09-30 | Bayer Ip Gmbh | Piperydyny podstawione heteroarylem |
| WO2011114103A1 (en) | 2010-03-18 | 2011-09-22 | Biolipox Ab | Pyrimidinones for use as medicaments |
| JO2998B1 (ar) | 2010-06-04 | 2016-09-05 | Amgen Inc | مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان |
| JP6093770B2 (ja) | 2011-09-27 | 2017-03-08 | アムジエン・インコーポレーテツド | 癌の治療のためのｍｄｍ２阻害剤としての複素環化合物 |
| US11407721B2 (en) | 2013-02-19 | 2022-08-09 | Amgen Inc. | CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
| CN105121407B (zh) | 2013-02-28 | 2017-07-18 | 美国安进公司 | 用于治疗癌症的苯甲酸衍生物mdm2抑制剂 |
| MX2015012427A (es) | 2013-03-14 | 2016-01-12 | Amgen Inc | Compuestos de morfolinona de acido heteroarilo como inhibidores mdm2 para el tratamiento de cancer. |
| JOP20200296A1 (ar) | 2013-06-10 | 2017-06-16 | Amgen Inc | عمليات صنع وأشكال بلورية من mdm2 مثبط |
| CN109400567A (zh) * | 2018-12-05 | 2019-03-01 | 华中药业股份有限公司 | 一种合成甘草素的方法 |
| CN116327758A (zh) | 2019-12-17 | 2023-06-27 | 奇努克医疗公司 | 用阿曲生坦治疗IgA肾病的方法 |
| TW202328111A (zh) * | 2021-09-03 | 2023-07-16 | 大陸商深圳信立泰藥業股份有限公司 | 內皮素ａ（ｅｔａ）受體拮抗劑化合物、其藥物組合物及其用途 |
| WO2024022262A1 (zh) * | 2022-07-25 | 2024-02-01 | 深圳信立泰药业股份有限公司 | 一种内皮素a(eta)受体拮抗剂化合物的盐及其制备方法和医药用途 |
| WO2024092240A1 (en) | 2022-10-28 | 2024-05-02 | Chinook Therapeutics, Inc. | Treatment of iga nephropathy using an endothelin receptor antagonist and an april binding antibody |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2667294B2 (ja) * | 1991-11-05 | 1997-10-27 | スミスクライン・ビーチャム・コーポレイション | エンドセリン受容体拮抗剤 |
| DE69327720T2 (de) * | 1992-07-17 | 2000-07-27 | Smithkline Beecham Corp., Philadelphia | Endothelin rezeptor antagonisten |
| EP0776324B1 (en) * | 1994-08-19 | 2002-06-12 | Abbott Laboratories | Endothelin antagonists |
-
1997
- 1997-02-12 ES ES97905816T patent/ES2259803T3/es not_active Expired - Lifetime
- 1997-02-12 AT AT97905816T patent/ATE323697T1/de not_active IP Right Cessation
- 1997-02-12 NZ NZ330818A patent/NZ330818A/xx not_active IP Right Cessation
- 1997-02-12 PT PT97905816T patent/PT885215E/pt unknown
- 1997-02-12 EP EP97905816A patent/EP0885215B1/en not_active Expired - Lifetime
- 1997-02-12 CN CN97192184A patent/CN1091768C/zh not_active Expired - Lifetime
- 1997-02-12 JP JP52939797A patent/JP2002504081A/ja active Pending
- 1997-02-12 CA CA002634973A patent/CA2634973A1/en not_active Abandoned
- 1997-02-12 EP EP05106190A patent/EP1609790A3/en not_active Withdrawn
- 1997-02-12 CA CA002245587A patent/CA2245587C/en not_active Expired - Fee Related
- 1997-02-12 IL IL12517797A patent/IL125177A0/xx active IP Right Grant
- 1997-02-12 BR BR9707509A patent/BR9707509A/pt not_active IP Right Cessation
- 1997-02-12 CZ CZ0253798A patent/CZ296660B6/cs not_active IP Right Cessation
- 1997-02-12 WO PCT/US1997/001936 patent/WO1997030045A1/en active IP Right Grant
- 1997-02-12 DE DE69735710T patent/DE69735710T2/de not_active Expired - Lifetime
- 1997-02-12 KR KR10-1998-0706247A patent/KR100508200B1/ko not_active IP Right Cessation
- 1997-02-12 DK DK97905816T patent/DK0885215T3/da active
- 1997-02-12 AU AU22620/97A patent/AU2262097A/en not_active Abandoned
- 1997-02-12 AR ARP970100553A patent/AR006309A1/es unknown
-
1998
- 1998-07-01 IL IL125177A patent/IL125177A/en not_active IP Right Cessation
-
2002
- 2002-02-09 CN CN02104623A patent/CN1384100A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1609790A3 (en) | 2006-01-04 |
| IL125177A (en) | 2007-12-03 |
| CA2245587A1 (en) | 1997-08-21 |
| WO1997030045A1 (en) | 1997-08-21 |
| AU2262097A (en) | 1997-09-02 |
| AR006309A1 (es) | 1999-08-25 |
| BR9707509A (pt) | 1999-07-27 |
| CA2245587C (en) | 2008-12-30 |
| CZ253798A3 (cs) | 1999-07-14 |
| CZ296660B6 (cs) | 2006-05-17 |
| ATE323697T1 (de) | 2006-05-15 |
| DE69735710D1 (de) | 2006-05-24 |
| KR100508200B1 (ko) | 2005-12-16 |
| JP2002504081A (ja) | 2002-02-05 |
| ES2259803T3 (es) | 2006-10-16 |
| EP0885215A1 (en) | 1998-12-23 |
| EP1609790A2 (en) | 2005-12-28 |
| CA2634973A1 (en) | 1997-08-21 |
| CN1219172A (zh) | 1999-06-09 |
| DK0885215T3 (da) | 2006-08-14 |
| CN1384100A (zh) | 2002-12-11 |
| IL125177A0 (en) | 1999-03-12 |
| NZ330818A (en) | 2000-05-26 |
| KR19990082514A (ko) | 1999-11-25 |
| EP0885215B1 (en) | 2006-04-19 |
| CN1091768C (zh) | 2002-10-02 |
| DE69735710T2 (de) | 2007-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT885215E (pt) | Novos derivados de pirrolidina substituidos com benzo-1,3-dioxolilo e benzofuranilo como antagonistas de endotelina | |
| PT832082E (pt) | Derivados de n-heteroaril-piridinossulfonamidas e sua utilizacao como antagonistas de endotelina | |
| DE69728586D1 (de) | Gesichtstissue mit verminderter feuchtigkeitsaufnahme | |
| BR9705088A (pt) | Derivados de 4-aminoquinazolina | |
| DE69727968D1 (de) | Ablations-katheter mit mehreren elektroden | |
| BR9708149A (pt) | Imidazois substituídos com cicloalquila | |
| BR9700850A (pt) | Derivados de quinazolina substituídos | |
| DE69718574D1 (de) | Einspritzventil | |
| DE59710379D1 (de) | Elektrodenanordnung | |
| EE05169B1 (et) | Asendatud oksasolidinoonid ja nende kasutamine | |
| DE69728356D1 (de) | Vernetzbare Zusammensetzung | |
| BR9708894A (pt) | Derivados de acilmercapto-triazolila e seu uso como microbicidas | |
| DE69725795D1 (de) | Einspritzventil | |
| FI963229A (fi) | Ruiskutusventtiilijärjestely | |
| BR9709107A (pt) | Derivados de tiocianato-triazolila e seu uso como microbicidas | |
| BR9709258A (pt) | Derivados de sulfonil-mercaptotriazolila e seu uso como microbicidas | |
| DE69720570D1 (de) | Injektor | |
| DE69712542D1 (de) | Einspritzventil | |
| DE69713512D1 (de) | Substituierte phtalocyanine und deren verwendung | |
| PT923550E (pt) | Derivados de acilaminoalcenileno-amida como antagonistas de nk1 e nk2 | |
| BR9709906A (pt) | Derivados de benzamida substituídos e o uso dos mesmos como anticonvulsivantes | |
| BR9709532A (pt) | Derivados de pirazolil-pirazol substítuidos e seu emprego como herbicidas | |
| DE69706167D1 (de) | Einspritzvorrichtung | |
| DE69714385D1 (de) | Einspritzventil | |
| BR9710757A (pt) | Fibras microporosas com propiedades aperfei-oadas |